Irene Agraz

2.0k total citations
39 papers, 533 citations indexed

About

Irene Agraz is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Irene Agraz has authored 39 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Irene Agraz's work include Renal Diseases and Glomerulopathies (19 papers), Chronic Kidney Disease and Diabetes (7 papers) and Vasculitis and related conditions (7 papers). Irene Agraz is often cited by papers focused on Renal Diseases and Glomerulopathies (19 papers), Chronic Kidney Disease and Diabetes (7 papers) and Vasculitis and related conditions (7 papers). Irene Agraz collaborates with scholars based in Spain, Palestinian Territory and France. Irene Agraz's co-authors include Natàlia Ramos, María José Soler, Daniel Serón, Clara García-Carro, Josefina Cortés-Hernández, Cristina Solé, Marta Vidal, Josep Ordi‐Ros, Teresa Moliné and Eugènia Espinel and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of the Rheumatic Diseases and Transplantation.

In The Last Decade

Irene Agraz

32 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irene Agraz Spain 14 222 137 116 102 96 39 533
Shin Okuyama Japan 13 321 1.4× 188 1.4× 110 0.9× 119 1.2× 82 0.9× 38 527
Zheng Tang China 16 264 1.2× 239 1.7× 185 1.6× 178 1.7× 121 1.3× 51 796
Douglas Charney United States 12 98 0.4× 92 0.7× 61 0.5× 70 0.7× 38 0.4× 18 540
Toshiharu Ueno Japan 16 408 1.8× 143 1.0× 58 0.5× 153 1.5× 50 0.5× 45 666
Roberta Camilla Italy 13 606 2.7× 131 1.0× 104 0.9× 164 1.6× 186 1.9× 24 766
Norihisa Akano Japan 14 332 1.5× 86 0.6× 92 0.8× 117 1.1× 171 1.8× 26 627
Dita Maixnerová Czechia 17 464 2.1× 99 0.7× 126 1.1× 97 1.0× 117 1.2× 38 656
O. Bogenschütz Germany 7 451 2.0× 145 1.1× 39 0.3× 152 1.5× 99 1.0× 11 717
G Pannarale Italy 10 156 0.7× 117 0.9× 117 1.0× 179 1.8× 104 1.1× 15 504
C. Bätz Germany 6 552 2.5× 184 1.3× 48 0.4× 160 1.6× 95 1.0× 7 821

Countries citing papers authored by Irene Agraz

Since Specialization
Citations

This map shows the geographic impact of Irene Agraz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Agraz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Agraz more than expected).

Fields of papers citing papers by Irene Agraz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Agraz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Agraz. The network helps show where Irene Agraz may publish in the future.

Co-authorship network of co-authors of Irene Agraz

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Agraz. A scholar is included among the top collaborators of Irene Agraz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Agraz. Irene Agraz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Azancot, María, Irene Agraz, Sheila Bermejo, et al.. (2025). Real-World Impact of Finerenone on Albuminuria in Patients with Diabetes and CKD. International Journal of Molecular Sciences. 26(23). 11584–11584.
2.
Martín, Maria Carmen, Irina B. Torres, Irene Agraz, et al.. (2024). Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy. Kidney International Reports. 9(7). 2227–2239. 2 indexed citations
3.
Agraz, Irene, Ander Vergara, Natàlia Ramos, et al.. (2022). COVID-19 infection and renal injury: where is the place for acute interstitial nephritis disease?. Clinical Kidney Journal. 15(9). 1698–1704. 7 indexed citations
4.
Alperí, Mercedes, et al.. (2022). MO073: Ex Vivo C5B9 Deposition Test as a Diagnostic and Monitoring Tool For Primary and Transplantation Associated AHUS. Nephrology Dialysis Transplantation. 37(Supplement_3).
5.
Jacobs-Cachá, Conxita, Ander Vergara, Jacobo Sellarés, et al.. (2021). A Specific Tubular ApoA-I Distribution Is Associated to FSGS Recurrence after Kidney Transplantation. Journal of Clinical Medicine. 10(10). 2174–2174. 2 indexed citations
6.
García-Carro, Clara, Irene Agraz, Néstor Toapanta, et al.. (2021). COVID-19 in CKD Patients: Lessons from 553 CKD Patients with Biopsy-Proven Kidney Disease. Kidney & Blood Pressure Research. 46(4). 452–459. 1 indexed citations
7.
García-Carro, Clara, Irene Agraz, Iratxe Díez Miranda, et al.. (2020). Biopsia renal transyugular. La alternativa a la biopsia percutánea en pacientes de alto riesgo. Nefrología. 40(6). 634–639.
8.
Jacobs-Cachá, Conxita, Ander Vergara, Clara García-Carro, et al.. (2020). Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers. Clinical Kidney Journal. 14(2). 482–491. 18 indexed citations
9.
García-Carro, Clara, Ander Vergara, Irene Agraz, et al.. (2019). The New Era for Reno-Cardiovascular Treatment in Type 2 Diabetes. Journal of Clinical Medicine. 8(6). 864–864. 18 indexed citations
10.
Segarra, A., et al.. (2019). Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience. Lupus. 29(2). 118–125. 49 indexed citations
11.
Segarra-Medrano, Alfons, et al.. (2019). Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody–associated Vasculitis: Influence on the Disease Outcome. The Journal of Rheumatology. 47(3). 407–414. 31 indexed citations
12.
Segarra, Alfons, Irene Agraz, Natàlia Ramos, et al.. (2017). Mesangial C4d Deposits in Early IgA Nephropathy. Clinical Journal of the American Society of Nephrology. 13(2). 258–264. 50 indexed citations
13.
Espinel, Eugènia, Irene Agraz, Meritxell Ibernón, et al.. (2015). Renal Biopsy in Type 2 Diabetic Patients. Journal of Clinical Medicine. 4(5). 998–1009. 53 indexed citations
14.
Loureiro-Amigo, José, et al.. (2011). Amiloidosis secundaria en un paciente infectado por el VIH. Nefrología. 31(6). 759–760. 1 indexed citations
15.
Guirado, Lluís, José Muñóz, Núria Rabella, et al.. (2002). Use of cytomegalovirus antigenemia as a marker for preemptive treatment. Transplantation Proceedings. 34(1). 67–68. 2 indexed citations
16.
Cases, Aleix, et al.. (2002). Análisis de la frecuencia cardíaca como factor de riesgo asociado a la progresión de la insuficiencia renal crónica. Medicina Clínica. 119(7). 245–248. 1 indexed citations
17.
Díaz, Montserrat, et al.. (2002). Are there differences in renal posttransplant evolution between the first and the second recipient from the same donor?. Transplantation Proceedings. 34(1). 347–348. 2 indexed citations
18.
Agraz, Irene, et al.. (1999). Renal transplantation and graft survival and its influencing factors. Transplantation Proceedings. 31(6). 2296–2300. 4 indexed citations
19.
Guirado, L., R. Solà, Irene Agraz, et al.. (1998). Elderly donors (60 to 87 years) in renal transplantation: good results after 5 years. Transplantation Proceedings. 30(5). 2276–2276. 4 indexed citations
20.
Paredes, David, R. Solà, Lluís Guirado, et al.. (1997). Treatment of kidney transplants with chronic rejection using angiotensin-converting enzyme inhibitors. Transplantation Proceedings. 29(6). 2587–2588. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin Okuyama Breakdown of academic impact, for papers by Zheng Tang Breakdown of academic impact, for papers by Douglas Charney Breakdown of academic impact, for papers by Toshiharu Ueno Breakdown of academic impact, for papers by Roberta Camilla Breakdown of academic impact, for papers by Norihisa Akano Breakdown of academic impact, for papers by Dita Maixnerová Breakdown of academic impact, for papers by O. Bogenschütz Breakdown of academic impact, for papers by G Pannarale Breakdown of academic impact, for papers by C. Bätz
Rankless by CCL
2026